189 results
Page 8 of 10
6-K
EX-99.1
wtzcghil
2 May 18
RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO
12:01pm
20-F/A
05zm6o6bksjce
12 Jan 18
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
qiqlyy6a3sybhva2n
25 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.2
07216tfmc8xe1
13 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
bte68usx2u1yy
13 Oct 17
Current report (foreign)
12:00am
6-K
EX-99.1
j9ebfmsi
20 Apr 16
RepliCel Life Sciences Finishes Enrolment for its Tendon Repair and Skin Rejuvenation Clinical Trials
12:00am
6-K
EX-99.1
r0d15gilbk4g6a0a
6 Apr 16
Replicel Life Sciences Announces Restructuring, Cost Reductions and Closing
12:00am
6-K
EX-99.1
ys1f9em97 c8l
20 Oct 15
First Participants Enrolled in RepliCel's Phase 1 Clinical Trial of its RCS-01 Dermatology Injectable
12:00am
6-K
EX-99.1
7hvrq
23 Jul 15
RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
12:00am
6-K
EX-99.1
np7q9n
23 Feb 15
RepliCel Submits Clinical Trial Application for its Dermatological Product
12:00am
6-K
EX-99.1
8ft0d58k
21 Jan 15
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
12:00am
6-K
EX-99.1
t9qljuu4ogeda0o sw59
7 Jan 15
RepliCel Life Sciences to Present at Biotech Showcase 2015 in San Francisco
12:00am
CORRESP
9fengs
6 Jan 15
Correspondence with SEC
12:00am
6-K
EX-99.1
589lmpdqeykez0 s86
22 Dec 14
Current report (foreign)
12:00am
6-K
EX-99.1
g0fpkv pminqs
1 Dec 14
RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis
12:00am
6-K
EX-99.2
o4exeq7
26 Nov 14
Condensed Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
fyn89wgytlwjaka9qgov
26 Nov 14
RepliCel Announces 2014 Third Quarter Financial Results
12:00am